by University of California, Irvine Estimated 10-year cardiovascular disease risk and projected number of cardiovascular events (in millions) in 10 years without and with semaglutide treatment, among us adults without cardiovascular disease who are overweight or obese. Data adapted from Wong ND et al., Cardiovasc Drug Therapy 2023. Credit: Dr. Nathan Wong, UC Irvine School of...
